Clinical Trial Update: Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

View source ↗

Summary

Clinical trial update on piperacillin/tazobactam for complicated urinary infections. The sponsor Wyeth is now a wholly owned subsidiary of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Urinary Infections | Status: COMPLETED